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ABSTRACT
The prevalence of erectile dysfunction (ED) was reported to vary from 37.5 to 
52% in men above 40. Type 2 diabetes mellitus (T2DM) maycause the nerves 
and blood vessels damages that worsened the ED. This study aimed to evaluate 
the correlation between the glucose control index and the erection hardness 
score (EHS) among T2DM patients. The cross-sectional observational study 
was conducted in two district hospitals i.e. Manambai Abdulkadir District 
Hospital, Sumbawa, and Dompu District Hospital, Dompu, West Nusa Tenggara, 
Indonesia. Forty-five patients with T2DM were involved in this study. Data were 
collected using structural questioners during the period from June 1st to August 
1st, 2017 and were analyzed using SPSS 24.0. Pearson correlation and logistic 
regression analysis were used to determine the odds ratio (OR). Among 45 
patients having age 57.38± 7.22 years involved in this study, 38 (84.4%) patients 
had ED, 26 (57.8%) uncontrolled DM, 5 (11.1%) congestive heart failure (CHF), 
4 (8.9%) chronic kidney diseases (CKD), and 7 (15.6%) neuropathy diabetic. 
A strong correlation between random glucose level and IIEF-5 score (r=0.91; 
p=0.01) was observed. The overall odds ratio of ED in this study was 4.3 (95% 
CI: 0.73 to 25.1) for uncontrolled DM, 2.5 (95% CI: 0.1 to 51.1) for CHF, 2 (95% 
CI: 0.01 to 41.6) for CKD, and 1.2 (95% CI: 0.1 to 11.5) for neuropathy diabetics. 
In conclusion, there is a strong correlation between random glucose level, 
duration of diagnosed DM and EHS. Active screening is recommended for this 
population.
ABSTRAK
Prevalensi disfungsi ereksi (DE) dilaporkan bervariasi antara 37.5 hingga 52 
% pada laki laki berusia diatas usia 40. Diabetes melitus tipe 2 (DMT2) dapat 
menyebabkan kerusakan jaringan syaraf dan pembuluh darah yang dapat 
memperburuk kondisi DE. Penelitian ini bertujuan mengkaji hubungan 
antara indeks control glukosa dan skor kekerasan ereksi (SKE) pada penderita 
DMT2. Penelitian ini merupakan penelitian potong lintang dilakukan di RSUD 
Manambai Abdulkadir, Sumbawa dan RSUD Dompu, Dompu, Nusa Tenggara 
Barat, Indonesia. Empat puluh lima pasien DMT2 diikutkan dalam penelitian 
ini. Data diperoleh menggunakan kuisioner terstruktur periode 1 Juni sampai 
1 Agustus 2017 dan dianalisis menggunakan SPSS 24.0. Analisis regresi analitik 
dan korelasi Pearson digunakan untuk menentukan odds ratio (OR). Di antara 
45 pasien yang berumur 57,38 ± 7,22 tahun yang terlibat dalam penelitian ini, 
38 (84,4%) pasien mengalami DE, 26 (57,8%) DMT2 tidak terkontrol, 5 (11,1%) 
gagal jantung kongestif (GJK), 4 (8,9%) penyakit ginjal kronik, (PGK), and 7 
(15,6%) diabetes neuropati. Ada hubungan yang kuat antara kadar gula darah 
acak dengan skor IIEF-5 (r=0,91; p=0,01). Odd ratio keseluruhan dari DE pasien 
ini adalah 4,3 (95% CI: 0,73 - 25,1) untuk DM tidak terkontrol, 2,5 (95% CI: 0,1–
51,1) untuk GJK, 2 (95% CU: 0,01 – 41,6) untuk PGK, dan 1,2 (95% CI: 0,1 – 11,5) 
untuk diabetes neuropati. Dapat disimpulkan, terdapat hubungan kuat antara 
kadar gula darah acak, durasi terdiagnosis DM dengan SKE. Skrining aktif 
direkomendasikan pada populasi pasien ini. 
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INTRODUCTION
Erectile dysfunction (ED) is defined 
as a failure to achieve or maintain 
the erection of the penis for sufficient 
sexual intercourse.1 The ED mostly 
affects elderly men with the number of 
cases approximately 30 up to 50% in the 
population. The data of ED remain as an 
iceberg due to the majority of cases are 
undiagnosed.2,3
Type 2 diabetes mellitus (DM) is one 
of major risk factors for ED. Inadequate 
glycemic control is known as one of the 
major factors that lead to an abnormality 
of neurovascular inducing the ED. A 
cross-sectional study reported that the 
ED cases are commonly found in patients 
with particular conditions, such as DM, 
the advancement of age, and chronicity 
of diseases.4
Increasing age is positively 
correlated to the prevalence and degree 
of ED. Data showed that moderate and 
complete ED among age was different, 
among men in the forties there was 8%, 
meanwhile, there was 40% in men aged 
60-69. Massachusetts Male Aging Study 
(MMAS) estimated the possibility of the 
increasing number of ED worldwide 
between 1995 and 2025. This estimation 
is based on the age-adjusted data of the 
recent men population which is increased 
from 152 million to 322 million.2 The 
International Diabetes Federation (IDF) 
also estimates that there are 425 million 
people worldwide who have diabetes 
and approximately 20 up to 85% of 
them have ED. Among the ED patients, 
those with diabetes are likely to have 
experienced the symptoms 10-15 years 
earlier than men without diabetes.5 Thus 
increasing age is positively correlated to 
the prevalence of T2DM and the degree 
of ED.
Although the ED is not a life-
threatening condition, it is strongly 
associated with physical health, 
psychosocial health, the outcome of 
therapy, and hence it determines the 
quality of life. This study was aimed 
to investigate the impact of ED among 
T2DM patients and the impact of glucose 
control in the erection hardness domain.
MATERIALSAND METHODS
Design and subjects
The cross-sectional observational 
study was performed at Manambai 
Abdulkadir District Hospital, Sumbawa, 
and Dompu District Hospital, Dompu, 
West Nusa Tenggara, Indonesia. The 
male out patients diagnosed with T2DM 
were enrolled in this study. All samples 
were collected from the outpatients in 
the Department of Internal Medicine. 
All patients with histories of spinal 
cord injury, stroke, Parkinson’s disease, 
prostate surgery, cancer, and major 
psychiatric problem were excluded. 
The blood samples were taken from 
both hospital laboratories and their 
classification was carried out using a 
national algorithm adopted from the 
American Diabetes Association (ADA) 
guidelines.
Protocol of study
In this study, we used the Indonesian 
version IIEF-5 (international index 
of erectile function) questioners and 
erectile hardness score (EHS) to evaluate 
the ED of patients. The patients were 
interviewed to avoid bias in answering 
questioner. The current mental condition 
was assessed using the patient’s health 
questionnaire 9 (PHQ9). The patients 
were interviewed by the general 
practitioner (GP) to avoiding bias in the 
patient perspective to answering the 
PHQ9. Patients with a score of more 
than 5 that indicate patients with mild 
or worse depression condition were 
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excluded. This study received approval 
from the Manambai Abdulkadir District 
Hospital Ethical Review Board (800/892/
RSMA/VII).
Forty-five consecutive males whom 
favorable inclusion and exclusion 
criteria were enrolled in this study. The 
blood venous samples were taken in the 
outpatient department after interviews 
were completed. The cut point of 
regulated DM was used ADA guidelines 
and current national guidelines that 
indicated 200 mg/dL as regulated DM.
Statistical analysis
Data were presented as mean ± 
standard deviation (SD) or frequency 
and analyzed using SPSS 24.0. Pearson 
correlation and logistic regression 
analysis were used to find the odds ratio 
(OR).
RESULTS
A total of 45 men completed 
the questionnaire and their clinical 
characteristics are presented in TABLE-1.
TABLE 1. Data of demographics
Variable Sum
Age (mean ± SD years) 57.38 ± 7.22
ED Defined by IIEF-5 [n (%)] 39 (83)
•	 Mild 15 (33)
•	 Mild-moderate 9 (20)
•	 Moderate 8 (18)
•	 Severe 7 (16)
ED Defined by EHS [n (%)] 38 (80.9)
Duration of DM(mean ± SD years) 3.89 (3.6)
Status of DM [n (%)]
•	 Controlled 19 (42.2)
•	 Uncontrolled 26 (57.8)
CKD [n (%)] 4 (8.9)
CHF[n (%)] 5 (11.1)
Neuropathy [n (%)] 7 (15.6)
Hypertension [n (%)] 15 (33.3)
•	 Regulated 8 (17.7)
•	 Unregulated 7 (15.6)
Overall, 39 (84.4%) and 38 (80.9%) 
of T2DM patients had ED that defined 
by IIEF-5 and EHS respectively, and the 
majority of patients had mild ED (15) 
(TABLE 1). The duration of DM was 
approximately 3.89 years. Among 45 
patients who had T2DM, 26 (57.8%) of 
them was an uncontrolled glucose index.
The overall odds ratio of ED in this 
study were 4.3 (95% CI: 0.73 to 25.1) 
for uncontrolled diabetes, 2.5 (95% CI: 
0.1 to 51.1) for CHF, 2 (95% CI: 0.01 to 
41.6) for CKD, and 1.2 (95% CI: 0.1 to 
11.5) for neuropathy diabetics (TABLE 
2). In this study, we found that EHS and 
IIEF-5 also demonstrated similar results 
on diagnosed ED patients which both 
of them exhibited a medium inverse 
correlation to ED severities (Spearman 
rho 0.91; p<0.001) as presented in 
FIGURE 1.In addition, the duration of DM 
also has a medium inverse correlation 
(Spearman rho 0.349, p = 0.016).
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TABLE 2. Univariate analysis risk of ED
Variables  OR 95% CI
Uncontrolled DM 4.3 0.73 -25.1
Congestive heart failure 2.5 0.1 -51.1
Chronic kidney diseases 2 0.01 - 41.6
Neuropathy 1.2 0.1 - 11.5
Fisher exact test; Chi-square analysis
FIGURE 1. Correlation between EHS and random glucose index 
(Spearman rho – 0.35; p = 0.020).
FIGURE 2. Correlation between EHS and Random glucose Index 
(Spearman rho – 0.349; p=0.016).
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DISCUSSION
Sexual dysfunction is reported mostly 
in patients with T2DM.It can be caused 
by physical abnormality, psychological 
condition, or both of them. In terms of 
management of ED, the management 
of underlying diabetic condition 
hypothetically improves sexual quality. 
Currently, the glucose control impact on 
the erection hardnessis still less reported. 
In this study, 39 of the 45 patients had 
ED in all degree categories. Mostly, the 
ED patients hada multi-burden disease. 
Ahmed et al.6 also found a similar 
pattern. Approximately 97.2% T2DM 
patients had ED in term all severity of 
ED were included.  Erectile dysfunction 
has  been known as one of the negative 
predictors of poor quality of life in 
patients with T2DM due to its negative 
effect on male self-esteem, depression, 
and anxiety.7-9 Hence, actively screening 
ED among T2DM patients is needed for 
diagnosis purposes and to improvethe 
quality of life T2DM patients. 
Glycemic control correlates with 
the development of ED and furthers 
complications of T2DM; tight glycemic 
control has been advocated for decades. 
Despite being campaigned poor glycemic 
control remains found in a wide 
population, on this study we found that 
the majority of patients (57.8%) still have 
unregulated glycemic blood levels. A 
significant inverse correlation between 
blood glycemic level and severity of 
ED was demonstrated in this study. 
This data suggests that poor glycemic 
controls worsen the severity of ED. 
Several studies support our finding,10-15 
whereas other studies did not report 
any correlation.16,17 The result from each 
study may vary due to the chronicity of 
T2DM, time of diagnosis, hypertension, 
hyperlipidemia, overweight, obesity, 
metabolic  syndrome,  smoking, 
sedentary lifestyles, and autonomic 
neuropathy, which are recognized as 
risk factors for ED that found different 
on the baseline of each studies.18-20
Erectile hardness scoreis known 
as a tool for an evaluation of the 
management of ED that focusing on 
assessing dimensions of erection 
hardness. This study illustrating that the 
glucose index has an inverse correlation 
with erectile hardness. High glucose 
index is known as a scavenger that 
slowing nerve conduction and altered 
vascular reactivity that may result in a 
worsened erectile hardness score.21 To 
the best of our knowledge, our study is 
the first data that evaluate the glucose 
index and erectile hardness score. The 
nature of random glucose index may 
present as cross-sectional data is one 
of the limitations of this study. Further, 
the duration of diabetes was also found 
as a confounding factor in this study. 
The longer duration of T2DM indicated 
the worsened erection hardness score. 
Besides, most patients in this study 
did not seek medical advice for their 
current condition, this condition makes 
the patient could be considered as silent 
suffers. The active screening of ED on 
the patient with the duration of T2DM 
and unregulated blood glucose index is 
advisable. The future direction of this 
study is to evaluate the reversibility of 
low EHS scores among T2DM after tight 
regulation of the blood glucose index.
In the term of limitation, our cross-
sectional study conducted in a relatively 
small number of subjects. The major 
obstacle was  the large proportion 
patient with T2DM patients were have 
moderate-severe depression while 
screened with PHQ9 questioner, several 
patients also reported underwent TURP 
and others procedure that may affect the 
quality of erection. The major strength 
of our study is to perform strong data 
with strict exclusion criteria. However, 
Studies in larger subjects are needed. 
Despite the aforementioned 
limitation, this study indicated the 
early screening of ED among T2DM, 
and regulate underlying diseases may 
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pivotal role to improve the management 
outcome in a specific condition and the 
specific therapy addressed the sexual 
concerns is needed.
CONCLUSION
The poor glycemic control and 
the long duration of T2DM are poor 
predictors of erection hardness score 
(EHS). Healthcare Professionals should 
be encouraged to initiate an open 
dialogue of sexual issues to identify 
patients with ED who may not otherwise 
volunteer their sexual concerns.
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